• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Introduction to 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride (CAS No. 155542-32-8) in Modern Chemical and Pharmaceutical Research

4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride, identified by the chemical abstracts service number 155542-32-8, is a significant compound in the realm of medicinal chemistry and drug development. This compound belongs to the piperidine class of heterocyclic amines, which are widely recognized for their versatility in pharmaceutical applications due to their unique structural and functional properties. The presence of both an amine group and a carboximidamide moiety in its molecular structure endows it with distinctive reactivity and potential biological activity, making it a valuable scaffold for the synthesis of novel therapeutic agents.

The 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride molecule exhibits a high degree of structural complexity, which is reflected in its intricate stereochemistry and functional group interactions. This complexity has garnered considerable interest from researchers exploring its pharmacological potential, particularly in the context of developing small-molecule inhibitors and modulators for various diseases. The compound's ability to engage with biological targets through multiple binding interactions makes it an attractive candidate for further investigation.

In recent years, there has been a surge in research focused on developing innovative therapeutic strategies that leverage the unique properties of piperidine derivatives. Among these, 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride has emerged as a promising intermediate in the synthesis of compounds with potential applications in oncology, neurology, and anti-inflammatory therapies. Its structural features allow for modifications that can enhance binding affinity and selectivity against specific biological targets, thereby improving therapeutic efficacy while minimizing side effects.

One of the most compelling aspects of 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride is its role as a building block in the design of peptidomimetics. Peptidomimetics are synthetic analogs of natural peptides that mimic their biological activity but with improved stability and pharmacokinetic properties. The compound's ability to serve as a scaffold for peptidomimetic design has opened new avenues for drug discovery, particularly in the development of targeted therapies for cancer and infectious diseases. Researchers have demonstrated that modifications to the 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride core can yield derivatives with enhanced potency and selectivity against key enzymes and receptors involved in disease pathways.

The synthesis of 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, including transition-metal-catalyzed cross-coupling reactions and asymmetric hydrogenation, have been employed to construct the desired molecular framework efficiently. These synthetic strategies not only highlight the compound's synthetic accessibility but also underscore its importance as a versatile intermediate in medicinal chemistry.

Recent studies have explored the pharmacological profile of derivatives derived from 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride, revealing intriguing biological activities. For instance, certain analogs have shown significant inhibitory effects on kinases involved in tumor growth and progression. Additionally, modifications to the amine and carboximidamide groups have led to compounds with potent anti-inflammatory properties, making them promising candidates for treating chronic inflammatory disorders such as rheumatoid arthritis. These findings underscore the compound's potential as a lead structure for drug development.

The use of computational chemistry techniques has further enhanced our understanding of how 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride interacts with biological targets. Molecular docking studies have been instrumental in predicting binding affinities and identifying key residues involved in target recognition. These insights have guided the rational design of novel derivatives with improved pharmacological properties. Furthermore, virtual screening approaches have been employed to identify potential lead compounds based on structural features similar to known bioactive molecules.

The development of novel therapeutic agents often involves rigorous preclinical testing to assess safety and efficacy before human trials can commence. In this context, 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride derivatives have undergone various preclinical studies, including cell-based assays, animal models, and pharmacokinetic evaluations. These studies have provided valuable data on the compound's metabolic stability, distribution, excretion, and potential toxicological effects. Such information is crucial for optimizing drug candidates before they enter clinical development.

The future prospects for 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride are bright, with ongoing research aimed at expanding its applications across multiple therapeutic areas. Innovations in synthetic chemistry continue to unlock new possibilities for designing structurally diverse derivatives with tailored biological activities. Additionally, advancements in biotechnology have enabled more efficient screening platforms for identifying novel drug candidates based on this scaffold. As our understanding of disease mechanisms evolves, so too does our ability to harness the potential of compounds like 4-(aminomethyl)piperidine-1-carboximidamide dihydrochloride to develop next-generation therapeutics.

• 774561-45-4(3,5-dimethylpiperidine-1-carboximidamide)
• 102392-91-6(Piperidine-1-carboximidamide Hydroiodide)
• 4705-39-9(piperidine-1-carboxamidine)
• 332367-56-3(Piperidine-1-carboximidamide hydrobromide)
• 1185133-68-9(4-Methyl-piperidine-1-carboxamidine hydrochloride)
• 1185294-26-1(3-Methyl-piperidine-1-carboxamidine hydrochloride)
• 73771-19-4(4-methylpiperidine-1-carboximidamide)
• 162696-05-1(Cyclohexanecarboximidamide,4-(aminomethyl)-)
• 52318-35-1(Piperidine-1-carboximidamide Hydrochloride)
• 41316-49-8(Piperidine-1-carboximidamide hydrochloride)